Eicke Latz

Eicke Latz is a Co-Founder and consultant at Odyssey Therapeutics since 2021. Prior to this, they were the Director at the Institute of Innate Immunity, University Hospitals Bonn, University of Bonn since 2009. In 2020, they were the Scientific Co-founder, Board Member at Dioscure Therapeutics, Co-Founder, Scientific Director, Chair of SAB at Stealth Biotech, and Scientific Co-founder and consultant at IFM Therapeutics since 2016. Eicke was also an Adjunct Professor at UMass Medical School since 2002, Cooperation Unit Leader at Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE) since 2011, and Adjunct Professor at Centre of Molecular Inflammation Research, CEMIR since 2008.

Eicke Latz obtained a Doctor of Medicine (M.D.) from Freie Universität Berlin in the field of Medicine. Eicke then obtained a Doctor of Medicine (M.D.) from Humboldt-Universität zu Berlin in the fields of Microbiology and Immunology and Medicine. Lastly, they attended The University of Göttingen in the field of Medicine.